Mankind Pharma Ltd. IPO

The company is India’s fourth largest pharmaceutical company in terms of Domestic Sales and second largest in terms of sales volume for the Financial Year 2022. It is engaged in developing, manufacturing and marketing a diverse range of pharmaceutical formulations across various acute and chronic therapeutic areas, as well as several consumer healthcare products.

RHP
View
DRHP
View
Open Date

2023-04-25

Close Date

2023-04-27

Mankind Pharma Ltd. IPO Details

Check out the issue details for Mankind Pharma Ltd. IPO as disclosed in SEBI.

IPO Price

₹ 1080

Price Band

₹ 1026 - 1080

Issue Size

4326.36 Cr.

Issue Type

Book Built

Open

2023-04-25

Close

2023-04-27

Listingprice

₹ 1300

ListingGain

20.37%

Listing Date

2023-05-09

CMP

₹ 2597.65

Current Return

140.52%

Mankind Pharma Ltd. News

Mankind Pharma informs about disclosure 15 Nov, 10:38AM Mankind Pharma informs about newspaper publication 6 Nov, 5:04PM Mankind Pharma - Quaterly Results5 Nov, 4:30PM Mankind Pharma - Quaterly Results5 Nov, 4:30PM Mankind Pharma - Quaterly Results5 Nov, 4:30PM Mankind Pharma submits intimation of board meeting 25 Oct, 5:20PM Mankind Pharma completes transaction to acquire 100% stake in Bharat Serums and Vaccines 24 Oct, 9:39AM Mankind Pharma informs about allotment of non-convertible debentures16 Oct, 4:08PM Mankind Pharma to transfer OTC business undertaking to MCPPL 4 Sep, 9:29AM Mankind Pharma informs about presentation20 Aug, 9:38AM Mankind Pharma informs about allotment under ESOP14 Aug, 5:13PM Mankind Pharma informs about investors meet 7 Aug, 11:57AM Mankind Pharma’s Q1FY25 consolidated net profit surges by 10%31 Jul, 3:57PM Mankind Pharma - Quaterly Results31 Jul, 2:47PM Mankind Pharma - Quaterly Results31 Jul, 2:47PM Mankind Pharma - Quaterly Results31 Jul, 2:47PM Mankind Pharma inks pact to acquire 100% stake in BSV26 Jul, 10:30AM Mankind Pharma informs about change in time of conference call 26 Jul, 9:58AM Mankind Pharma informs about newspaper advertisement10 Jul, 2:05PM Mankind Pharma informs about transcript of conference call22 May, 5:12PM

Company Financials

You can get the following financial statements of Mankind Pharma Ltd. as of now.

Company Name

Mankind Pharma Ltd.

Exchange

NSE: MANKIND BSE: 543904

  Profit Loss
  Balance Sheet
  Quarterly
  Shareholding
  Cash Flow

The details about the Mankind Pharma IPO is as:

  • The issue size of the IPO is 4326.36 Cr.
  • The price band for Mankind Pharma IPO is Rs 1026 to Rs 1080.
  • The shares of Mankind Pharma IPO will list on 9th May 2023.
  • The latest tentative GMP of Mankind Pharma IPO is Rs 97.
  • The shares of Mankind Pharma IPO is subscribed 15.32 Times as of 27th April 2023.

 

Mankind Pharma Ltd IPO Valuation

The approx valuation of Mankind Pharma Ltd IPO based on its price band and RHP/DRHP (prospectus) is:

Particulars Value
Upper Price Band Rs 1080
Existing Shares (Qty) 40.05 Cr
EPS  Rs 35.78
PE Ratio 30.18x
Industry PE 40.16x

 

Mankind Pharma Ltd IPO Issue Size

Mankind Pharma Ltd IPO issue size is 4326.36 Cr.

Issue Amount
Fresh Issue 0 Cr
Offer For Sale 4326.36 Cr

 

Mankind Pharma Ltd IPO Market Lot

An Individual can apply for a minimum 1 lot of 13 shares and a maximum of 14 lots of 182 shares. Find the details below:

Application Lot Shares Amount
 Minimum  1 13 Rs 14,040
 Maximum 14 182 Rs 1,96,560

 

Mankind Pharma Ltd IPO Offer

The shares of Mankind Pharma IPO is subscribed 15.32 Times as of 27th April 2023. The category-wise shares subscribed are as follows:

Category % Offered Subscription
Qualified Institutional Maximum 50% 49.16 Times
Non-Institutional Minimum 15% 3.80 Times
Retail Individual Minimum 35% 0.92 Times
Total   15.32 Times

 

Mankind Pharma IPO Grey Market Premium

As on GMP (Tentative)
28 April 2023 Rs 30
1 May 2023 Rs 80
2 May 2023 Rs 90
3 May 2023 Rs 80
4 May 2023 Rs 80
5 May 2023 Rs 97

Mankind Pharma IPO GMP is purely for informational purposes and invest in an IPO after thoroughly researching on your own.

 

Find below the dates for Mankind Pharma Ltd IPO:

Schedule Date
Basis of Allotment 3 May 2023
Refunds 4 May 2023
Credit to Demat Account 5 May 2023
IPO Listing Date 9 May 2023

Check allotment status

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 4794.41 5523.18 7486.22 8127.15 9264.81
Total Expenditure 3550.47 4151.05 5647.73 6429.29 6939.19
Operating Profit 1243.94 1372.13 1838.49 1697.86 2325.61
Other Income 93.85 154.5 203.81 162.78 266.64
Interest 11.1 8.23 47.54 28.23 15.08
Depreciation 61.77 78.19 123.33 269.58 317.61
Exceptional Items 0 0 0 0 0
Profit Before Tax 1264.92 1440.21 1871.44 1562.84 2259.57
Provision for Tax 306.7 355.83 482.01 314.58 436.16
Net Profit 958.23 1084.37 1389.42 1248.26 1823.41
Adjusted EPS (Rs.) 2.39 2.71 3.47 3.12 4.55

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 40.06 40.06 40.06 40.06 40.06
Total Reserves 3611.39 4694.21 6500.39 7743.85 9583.75
Borrowings 0 0 0 0 0
Other N/C liabilities 42.84 54.11 126.98 168.12 200.54
Current liabilities 815.77 1078.91 2271.27 1419.09 1593.36
Total Liabilities 4510.06 5867.29 8938.7 9371.12 11417.71
Assets
Net Block 939.25 981.95 2921.3 3136.89 3399.07
Capital WIP 143.93 165.51 355.28 437.83 112.88
Intangible WIP 3.69 0.06 31.28 56.95 74.7
Investments 1389.51 1500.86 1657.08 2040.76 2190.62
Loans & Advances 77.6 115.59 146.3 148.86 137.64
Other N/C Assets 10.17 16.04 14.45 36.1 15.08
Current Assets 1945.9 3087.28 3813.01 3513.72 5487.71
Total Assets 4510.06 5867.29 8938.7 9371.12 11417.71
* Other Non-current Liabilities include Net deferred Liabilities

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
Other Income 58.11 67.23 83.85 94.83 105.76
Profit Before Tax 574.93 576.35 544.86 577.37 770.45
Tax 128.14 89.28 90.69 93.12 168.01
Profit After Tax 446.79 487.07 454.17 484.25 602.44
Adjusted EPS (Rs) 11.15 12.16 11.34 12.09 15.04

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Sep 2024 74.87 0
Jun 2024 74.87 0
Mar 2024 74.88 0
Dec 2023 76.51 0
Sep 2023 76.5 0
* Figures given above are % of equity capital

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 1264.92 1440.21 1871.44 1562.84 2259.57
Adjustment 137.23 96.74 -4.16 227 161.91
Changes in Assets & Liabilities -168.42 -156.19 -585.61 294.21 -40.95
Tax Paid -274.12 -397.38 -460.22 -285.06 -397.55
Operating Cash Flow 959.61 983.38 821.44 1798.99 1982.97
Investing Cash Flow -395.68 -1127.16 -1360.27 -1040.61 -1919.22
Financing Cash Flow -558.91 88.87 578.63 -710.41 -8.68
Net Cash Flow 5.02 -54.91 39.81 47.96 55.07
X